CN101843745B - Chinese medicament for treating chronic hepatitis - Google Patents
Chinese medicament for treating chronic hepatitis Download PDFInfo
- Publication number
- CN101843745B CN101843745B CN2009102383159A CN200910238315A CN101843745B CN 101843745 B CN101843745 B CN 101843745B CN 2009102383159 A CN2009102383159 A CN 2009102383159A CN 200910238315 A CN200910238315 A CN 200910238315A CN 101843745 B CN101843745 B CN 101843745B
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- chinese
- parts
- chronic hepatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 28
- 206010008909 Chronic Hepatitis Diseases 0.000 title claims abstract description 13
- 208000006454 hepatitis Diseases 0.000 title claims abstract description 13
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 239000000843 powder Substances 0.000 claims description 17
- 239000002775 capsule Substances 0.000 claims description 16
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 11
- 241000180649 Panax notoginseng Species 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 9
- 241001529553 Scoparia <angiosperm> Species 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 9
- 238000005728 strengthening Methods 0.000 abstract description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 3
- 208000026435 phlegm Diseases 0.000 abstract description 3
- 208000010643 digestive system disease Diseases 0.000 abstract description 2
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 241000099774 Cuscuta salina Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241000972673 Phellodendron amurense Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 230000002440 hepatic effect Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010019668 Hepatic fibrosis Diseases 0.000 description 3
- 241000207961 Sesamum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- AXONCVPTTFHNOI-UHFFFAOYSA-N kairine Chemical compound C1=CC(O)=C2N(C)CCCC2=C1 AXONCVPTTFHNOI-UHFFFAOYSA-N 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 102000007562 Serum Albumin Human genes 0.000 description 2
- 108010071390 Serum Albumin Proteins 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 1
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000088 lip Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000007449 liver function test Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicament for treating chronic hepatitis, and belongs to the field of Chinese medicaments for treating digestive system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: baical skullcap root, root of rehmannia, virgate wormwood herb, radix pseudo-ginseng, lucid ganoderma, Chinese angelica, amur corktree bark, golden thread and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, and clearing heat, detoxicating and reducing phlegm, and has the advantages of obvious effect, exact medicinal effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment digestive system disease.
Background technology
The present field of Chinese medicines that is intended to treat chronic hepatitis, the deficiency of two aspects of existence: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.So that large quantities of chronic hepatitis patients are because of can not get the treatment of active drug, liver disease constantly develops, and clinical symptoms can not get alleviating, and the patient is seriously weak for a long time, dull pain in liver, liver function descend, hepatic fibrosis is serious etc., patient's life quality descends, and I and family members are dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of chronic hepatitis, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of chronic hepatitis adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Radix Scutellariae 3-20 part Radix Rehmanniae 4-30 part Herba Artemisiae Scopariae 5-40 part
Radix Notoginseng 3-20 part Ganoderma 2-15 part Radix Angelicae Sinensis 4-30 part
Cortex Phellodendri 3-20 part Rhizoma Coptidis 3-20 part
The Chinese medicine of this treatment chronic hepatitis is made by following method:
(1) by above-mentioned weight ratio, Radix Scutellariae, the Radix Rehmanniae, Herba Artemisiae Scopariae, Radix Angelicae Sinensis, Cortex Phellodendri, Rhizoma Coptidis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Modern medicine thinks that chronic hepatitis protracted course of disease, hypoimmunity are problems the most outstanding, most critical.Ganoderma, Radix Rehmanniae the body resistance strengthening and constitution consolidating, benefiting QI and nourishing blood in the side; Close Radix Notoginseng, Radix Angelicae Sinensis passage, nourishing blood, blood circulation promoting and blood stasis dispelling, last four flavors are the prosperous hemapodium of 5 gas mutually, enhancing human body immunity power; Be aided with the Herba Artemisiae Scopariae eliminating damp-heat, kind control the damp-heat accumulation liver and gall and jaundice occurs; Radix Scutellariae, Rhizoma Coptidis, Cortex Phellodendri heat-clearing and toxic substances removing, drying dampness to eliminate phlegm.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and the merit that blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing reduce phlegm, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
The Radix Scutellariae 50 gram Radix Rehmanniae 60 gram Herba Artemisiae Scopariaes 80 grams
Radix Notoginseng 50 kairine sesames 30 gram Radix Angelicae Sinensis 60 grams
Cortex Phellodendri 50 gram Rhizoma Coptidis 50 grams
Weight in accordance with regulations, with conventional water extraction process Radix Scutellariae, the Radix Rehmanniae, Herba Artemisiae Scopariae, Radix Angelicae Sinensis, Cortex Phellodendri, Rhizoma Coptidis are extracted, make extractum fine powder 105 grams, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 660 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
The Radix Scutellariae 120 gram Radix Rehmanniae 180 gram Herba Artemisiae Scopariaes 250 grams
Radix Notoginseng 100 kairine sesames 90 gram Radix Angelicae Sinensis 180 grams
Cortex Phellodendri 120 gram Rhizoma Coptidis 120 grams
By above-mentioned same method, make 1718 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
The Radix Scutellariae 200 gram Radix Rehmanniae 300 gram Herba Artemisiae Scopariaes 400 grams
Radix Notoginseng 200 kairine sesames 150 gram Radix Angelicae Sinensis 300 grams
Cortex Phellodendri 200 gram Rhizoma Coptidis 200 grams
By above-mentioned same method, make 2964 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
10 parts of 8 portions of Herba Artemisiae Scopariaes of 6 parts of Radix Rehmanniae of Radix Scutellariae
8 parts of 4 parts of Radix Angelicae Sinensis of 6 portions of Ganodermas of Radix Notoginseng
6 parts of 6 portions of Rhizoma Coptidis of Cortex Phellodendri
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
30 parts of 25 portions of Herba Artemisiae Scopariaes of 15 parts of Radix Rehmanniae of Radix Scutellariae
25 parts of 12 parts of Radix Angelicae Sinensis of 15 portions of Ganodermas of Radix Notoginseng
12 parts of 15 portions of Rhizoma Coptidis of Cortex Phellodendri
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science chronic hepatitis, through 15 routine clinical observations.Selecting the tcm diagnosis chronic hepatitis is standard: limb is soft weak, and is weak from head to foot; Poor appetite, abdominal distention, dyspepsia; Face is pitch-dark, hepatic face is arranged; Dull pain in liver; Hepatic fibrosis is serious; It is undesired that liver function transaminase continues, and other index such as plasma albumin, blood total bilirubin etc. are defective.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 8 examples, women's 7 examples do not have other serious disease, and the age is 53 years old-79 years old, 64.7 years old mean age.
Efficacy determination:
1, produce effects: weak alleviation, on one's body energetically; Poor appetite, abdominal distention, dull pain in liver are alleviated, and the hepatic region is comfortable; Hepatic face is taken on a new look to some extent, and it is pale that face becomes; The hepatic fibrosis inspection is alleviated obviously; Indexs such as liver function test transaminase, plasma albumin are obviously improved.
2, effective: weak solution, on one's body energetically, abdominal distention, poor appetite, hepatic face are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom is obviously improved.15 philtrums of clinical experiment, produce effects 7 people, effective 7 people, invalid 1 people, total effective rate 93.3%.
Claims (1)
1. a Chinese medicine for the treatment of chronic hepatitis is characterized in that, described Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Radix Scutellariae 3---40 parts in 20 parts of Radix Rehmanniae 4---30 portions of Herba Artemisiae Scopariaes 5---
Radix Notoginseng 3---30 parts of 20 portions of Ganodermas 2---15 parts of Radix Angelicae Sinensis 4---
20 parts of Cortex Phellodendris 3---20 portions of Rhizoma Coptidis 3---
The Chinese medicine of this treatment chronic hepatitis is made by following method:
(1) by above-mentioned weight ratio, Radix Scutellariae, the Radix Rehmanniae, Herba Artemisiae Scopariae, Radix Angelicae Sinensis, Cortex Phellodendri, Rhizoma Coptidis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, make Chinese medicine granules, powder, capsule, watered pill, tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102383159A CN101843745B (en) | 2009-11-18 | 2009-11-18 | Chinese medicament for treating chronic hepatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102383159A CN101843745B (en) | 2009-11-18 | 2009-11-18 | Chinese medicament for treating chronic hepatitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101843745A CN101843745A (en) | 2010-09-29 |
| CN101843745B true CN101843745B (en) | 2011-08-17 |
Family
ID=42768683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102383159A Expired - Fee Related CN101843745B (en) | 2009-11-18 | 2009-11-18 | Chinese medicament for treating chronic hepatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101843745B (en) |
-
2009
- 2009-11-18 CN CN2009102383159A patent/CN101843745B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101843745A (en) | 2010-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843787B (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN101843694B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843789A (en) | Chinese medicament for treating gout | |
| CN101850071B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843704B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843740B (en) | Chinese medicament for treating climacteric syndromes | |
| CN101850046B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843726B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843707B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843745B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843817B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843825B (en) | Chinese medicament for treating climacteric syndromes | |
| CN101884747B (en) | Traditional Chinese medicine for treating chronic nephritis | |
| CN101843693A (en) | Chinese medicament for treating diabetic nephropathy | |
| CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
| CN101850078B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843775A (en) | Chinese medicament for treating diabetic nephropathy | |
| CN101874870B (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN101843826B (en) | Chinese medicament for treating chronic kidney failure | |
| CN101843711B (en) | Chinese medicament for treating ichthyosis | |
| CN101843806B (en) | Chinese medicament for treating climacteric syndromes | |
| CN101843816B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843818B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843678B (en) | Chinese medicament for treating climacteric syndromes | |
| CN101879246A (en) | Traditional Chinese medicine for treating lupus erythematosus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: RUGAO RICH STEEL MACHINERY PARTS CO., LTD. Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20130710 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130710 Address after: 226500, Jiangsu, Rugao moved by the town, moved through the village of twenty-four groups Patentee after: Rugao Fu Steel Machinery Fittings Co., Ltd. Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |
|
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Guo Yongjie Inventor before: Liu Xinzhuang |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20171228 Address after: 134705 group two group of miner street in pines Town, Jiangyuan County, Jilin Province Patentee after: Guo Yongjie Address before: 226500, Jiangsu, Rugao moved by the town, moved through the village of twenty-four groups Patentee before: Rugao Fu Steel Machinery Fittings Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110817 Termination date: 20181118 |